| 04/08 | TAKEDA PHARMACEUTICAL : Quarterly Securities Report for the 1st Quarter |  |
| 03/08 | Poseida Therapeutics Shares Soar After Roche Collaboration | |
| 31/07 | Takeda liefert im ersten Quartal GJ2022 starke Ergebnisse; auf Kurs in Richtung der Jah.. |  |
| 31/07 | Takeda logra resultados sólidos en el primer trimestre del año fiscal 2022 y se encuent.. |  |
| 29/07 | Takeda Pharmaceutical's Fiscal Q1 Attributable Profit Slides 24% | |
| 28/07 | TRANSCRIPT : Takeda Pharmaceutical Company Limited, Q1 2023 Earnings Call, Jul 28, 2022 | |
| 28/07 | Takeda Posts Higher Fiscal Q1 Core Profit, Revenue | |
| 28/07 | Takeda Pharmaceutical's First-Quarter Net Profit Fell 24% From High Base | |
| 28/07 | Takeda sees quarterly profit drop 39% after last year's one-time gains | |
| 28/07 | Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Managem.. | |
| 28/07 | Takeda Pharmaceutical Company Limited Reports Earnings Results for the First Quarter En.. | |
| 28/07 | Takeda Pharmaceutical Company Limited Provides Consolidated Earnings Guidance for Year .. | |
| 28/07 | Takeda Pharmaceutical Company Limited Announces Dividend Guidance for Second Quarter an.. | |
| 22/07 | Takeda anuncia resultados positivos del ensayo clínico fundamental de fase 3 que evalúa.. | |
| 21/07 | Takeda gibt positive Topline-Ergebnisse der klinischen Phase-3-Studie zur Prüfung von H.. | |
| 21/07 | Takeda Pharmaceutical Says Phase 3 Trial of Autoimmune Disorder Treatment Met Primary E.. | |
| 21/07 | Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluatin.. | |
| 21/07 | Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluatin.. | |
| 21/07 | Dolphin Unit Closes $8 Million Purchase of High Reserve F&B in Cash-Stock Deal; Dolphin.. | |
| 20/07 | F-star Therapeutics to Grant Takeda License for Immuno-oncology Bispecific Antibody | |
| 18/07 | Takeda to Hold First Quarter Earnings Call on July 28 | |
| 15/07 | TAKEDA PHARMACEUTICAL : to Hold First Quarter Earnings Call on July 28 | |
| 12/07 | Takeda gibt die Einreichung seines Corporate-Governance-Berichts an die Tokioter Börse .. | |
| 12/07 | Takeda Anuncia la Presentación de su Informe de Gobierno Corporativo a la Bolsa de Valo.. | |
| 11/07 | Takeda Places Focus on Personalized Care and Innovation for Bleeding Disorders at ISTH .. | |
| 11/07 | Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock E.. | |
| 11/07 | TAKEDA PHARMACEUTICAL : I.Basic Views on Corporate Governance and Basic Information on Cap.. | |
| 05/07 | En medio de la suspensión de la FDA, Denali pone en marcha un estudio sobre el Alzheime.. | |
| 01/07 | Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Tri.. | |
| 01/07 | TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI | |
| 01/07 | Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE.. | |
| 01/07 | Takeda Pharmaceutical Company Limited Demonstrates Positive Results in the Prevention o.. | |
| 29/06 | TAKEDA PHARMACEUTICAL : Executive compensation overview | |
| 29/06 | TAKEDA PHARMACEUTICAL : Announces the Publication of its Annual Report on Form 20-F for FY.. | |
| 29/06 | TAKEDA PHARMACEUTICAL : ARTICLES OF INCORPORATION OF TAKEDA PHARMACEUTICAL COMPANY LIMITED.. | |
| 29/06 | TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors - Form 6-K | |
| 29/06 | Takeda Pharmaceutical Company Limited Announces New Assignments of Directors | |
| 29/06 | Takeda Pharmaceutical Company Limited Announces Board Appointments | |
| 29/06 | Takeda Pharmaceutical Company Limited Approves Dividend for the Year Ended March 31, 20.. | |
| 29/06 | TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors | |
| 28/06 | Takeda - Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin .. | |
| 27/06 | The New England Journal of Medicine publica los resultados del estudio de fase 2 de faz.. | |
| 27/06 | Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficienc.. | |
| 27/06 | Takeda and Arrowhead Announce Results from Phase 2 Study of Fazirsiran in Patients with.. | |
| 24/06 | Takeda Pharmaceutical to Absorb Businesses From Unit Nihon Pharmaceutical | |
| 22/06 | Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation.. | |
| 22/06 | Takeda Signs 15-Year Lease with BioMed Realty | |
| 17/06 | MARKETSCREENER'S WORLD PRESS REVIEW : June 17, 2022 | |
| 17/06 | Takeda, Nintendo among Japanese firms quietly celebrating weak yen | |
| 10/06 | Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Th.. | |
| 10/06 | TAKEDA PHARMACEUTICAL : Notice Concerning Disposal of Treasury Shares under the Long-Term .. | |
| 09/06 | La vacuna candidata de Takeda contra el dengue ofrece protección contra esta enfermedad.. | |
| 09/06 | Dengue-Impfstoffkandidat von Takeda bietet einer zulassungsrelevanten klinischen Studie.. | |
| 09/06 | Takeda Pharmaceutical Says Dengue Vaccine Candidate 84% Effective Against Hospitalizati.. | |
| 09/06 | Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Th.. | |
| 07/06 | Takeda Canada applauds Quebec's new Rare Disease Policy | |
| 02/06 | Asian ADRs Move Higher in Thursday Trading | |
| 02/06 | Takeda Pharmaceutical Company Limited - Notice Concerning Withdrawal of Shelf Registrat.. | |
| 01/06 | Takeda Pharmaceutical to Pass On Marketing Authorization of COVID-19 Vaccine Spikevax i.. | |
| 01/06 | Japan Index Posts Moderate Gains as Border Restrictions Ease; Mercari Shares Surge 7% | |
| 31/05 | Takeda präsentiert neueste Forschungsergebnisse aus Onkologie-Portfolio und Pipeline au.. | |
| 31/05 | Takeda und Moderna geben Pläne zur Übertragung der Marktzulassung für den COVID-19-Impf.. | |
| 31/05 | Takeda presenta en ASCO y EHA las últimas investigaciones de su cartera de productos y .. | |
| 31/05 | Takeda y Moderna anuncian su intención de transferir a Moderna la autorización de comer.. | |
| 31/05 | Takeda and Moderna Announce Plans to Transfer Marketing Authorization for SpikevaxTM CO.. | |
| 31/05 | Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO & EHA | |
| 31/05 | TAKEDA PHARMACEUTICAL : Current Report by Foreign Issuer (Form 6-K) | |
| 31/05 | TAKEDA PHARMACEUTICAL : Current Report by Foreign Issuer (Form 6-K) | |
| 31/05 | Moderna to Receive Marketing Authorization Transfer for COVID-19 Vaccine in Japan From .. | |
| 31/05 | Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax&trad.. | |
| 31/05 | Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™.. | |
| 31/05 | SANITÀ : il pharma rimane zavorrato (MF) |  |
| 30/05 | Takeda y Seagen destacan los datos del estudio de ADCETRIS® en combinación, que muestra.. | |
| 29/05 | Takeda und Seagen präsentieren Daten zu ADCETRIS®-Kombination, die statistisch signifik.. | |
| 27/05 | TAKEDA PHARMACEUTICAL : and Seagen to Highlight ADCETRIS Combination Data | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
